MedPath

Methapharm, Inc.

Methapharm, Inc. logo
🇺🇸United States
Ownership
Subsidiary
Established
1996-01-01
Employees
51
Market Cap
-
Website
https://methapharm.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

5

FDA:5

Drug Approvals

AMPICILLIN and SULBACTAM

Approval Date
Feb 14, 2024
FDA

Pantoprazole Sodium

Approval Date
Jan 5, 2024
FDA

Tranexamic Acid

Approval Date
Oct 18, 2023
FDA

Aridol Bronchial Challenge Test Kit

Approval Date
Feb 13, 2023
FDA

Asclera

Approval Date
Feb 9, 2023
FDA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.